|
VH and VL assignments and alignment of CDR 3 sequences The selected (NP 04, 12, 13 designated Pf NPNA-1 bind to the repeat epitope), all other NP clones were randomly picked after the panning procedure and were subsequently shown not to be reactive with the repeat epitope. Non-selected (R01-10) were randomly picked from the library prior to initiating panning. The peptide sequence of the heavy and light chain complementarity-determining region 3 (CDR3) is shown below. VH/VL families, segments and the number of differences from germline segments were determined by using the V BASE sequence directory (Tomlinson, I. M., Williams, S. C., Corbett, S. J., Cox, J. P. L. & Winter, G., MRC Centre for Protein Engineering, Cambridge, UK) and the DNAPLOT alignment package (Müller, W. & Althaus, H.-H., Köln University) |
||||||||
| clone code* |
VH family |
VH Segment |
Differences from germline |
VHCDR3 |
VL family |
VL Segment |
Differences from germline |
VLCDR3 |
|
|
||||||||
| PfNPNAl |
VH3 |
DP46 |
10 |
DRDSSSYFDS |
VkI |
L12a |
15 |
QQYNSYSGLT |
| NP04, NP12, NP13 |
VH3 |
DP46 |
10 |
DRDSSSYFDS |
VkI |
L12a |
QQYNSYSGLT |
|
| R01 |
VH1 |
4M28†‡ |
28(+6)* §- |
DSESVAQWRY |
VkIV |
DPK24 |
43 |
QQSLSPVWT |
| R02 |
VH3 |
COS-3‡ |
27 (+3)_ |
GVNWCSDY |
VkI |
DPK9 |
10 |
QQSYSTSWT |
| R03 |
VH5 |
DP73 |
35 |
LYTSIYYFDS |
VkIV |
DPK24 |
7 |
QQYYSTPLT |
| R04 |
VH3 |
DP46 |
8 |
DRVTNFWSGYFDY |
VkIII |
DPK22 |
13 |
QQYGSSPGFT |
| R05 |
VH3 |
DP58 |
23 |
DSTVKTVTKMRYGLD V |
VkIII |
DPK22 |
8 |
QQYGSSPFT |
| R06 |
VH1 |
4M28† |
12 |
DNYGDPGGGFDI |
VkIII |
DPK22 |
11 |
QQYGNSPRT |
| R07 |
VH5 |
DP73 |
9 |
RFWFGELYDAFDI |
VkIV |
DPK24 |
16 |
HQYYSTPQT |
| R08 |
VH5 |
DP73 |
34 |
LYTSIYYFDS |
VkIII |
DPK22 |
14 |
QQYGRSPWT |
| R09 |
VH3 |
V3-21† |
34 |
DQGGGWSSEVDS |
VkIII |
Vg |
5 |
QQRSNWPLT |
| R10 |
VH1 |
DP7‡ |
21 (+9)** |
ALYGHDAFDI |
VkI |
DPK4 |
12 |
PKYNSALHT |
| NP02 |
VH3 |
DP47 |
36 |
ERPYDAFDS |
VkIII |
DPK22 |
23 |
QQYSTSPPMYN |
| NP03 |
VH5 |
DP73 |
40 |
LYTSIYYFDS |
VkIII |
Vg |
17 |
KQRSKWPPIT |
| NP05 |
VH3 |
V3-48 |
14 |
EPRGAGTTLYFDY |
VkIII |
DPK22 |
22 |
QQYGGSPGYN |
| NP08 |
VH4 |
4.30† |
18 |
DRGVSSGWTFDC |
VkII |
DPK16 |
32 |
MQLTAFPWT |
| NP09 |
VH4 |
DP71 |
17 |
FRGGVAAGYDY |
VkIII |
DPK22 |
24 |
QHYRESCS |
| NP10 |
VH4 |
DP78 |
29 |
DRVRVPYYYIDV |
VkIII |
DPK22 |
15 |
QQYGTSPYS |
| NP11 |
VH3 |
VH3-8† |
12 |
DTTVTHYFDY |
VkI |
DPK9 |
21 |
QQSFSSPRT |
| NP14 |
VH1 |
DP88 |
20 |
GPGATIHYYYMDV |
VkI |
DPK8 |
18 |
QQLDNYPLT |
| NP15 |
VH5 |
DP73 |
36 |
LYTSIYYFDS |
VkIII |
DPK22 |
28 |
QQYGNSPPT |
|
*Phage clones were either selected from the library at random (prefix R) or after four rounds of panning against (NPNA)3C-BSA, eluting with free (NPNA)3 peptide (prefix NP). † The segment given the best DNAPLOT match, although the segment sequence has not been verified by duplication. ‡ Aligned after removal of the unusual sequence additions (see§,-, ‡,-, **). § Figure in brackets indicates an unusual sequence addition. - Sequence has two additional codons in CDR1. - Sequence has one additional codon in CDR1. ** Sequence has three additional codons in CDR2. | ||||||||
Chappel et al. Malaria Journal 2004 3:28 doi:10.1186/1475-2875-3-28 |
||||||||